Electromed Inc 's ability to collect accounts receivable sequentially worsen to 2.6, indicating more challenging environment then in the fourth quarter 2026, but still, it is a far cry from any concerns. Electromed Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 140 days, from 138 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 59 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 593, from overall ranking in the fourth quarter 2026 at 2965.

What is Receivable Turnover Ratio?
What is Electromed Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ELMD Receivables Turnover Ratio	(Sep 30 2026) I. Quarter	(Jun 30 2026) IV. Quarter	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter
Y / Y Receivable Change	22.26 %	20.86 %	20.51 %	15.3 %	10.69 %
Y / Y Revenue Change	15.34 %	8.97 %	15.85 %	15.77 %	10.42 %
Receivable Turnover Ratio (TTM)	2.6	2.64	2.71	2.75	2.74
ELMD's Total Ranking	# 593	# 2965	# 419	# 2768	#
Accounts Receivable average collection period days	140	138	135	133	133
Seq. Receivable Change	1.55 %	5.5 %	7.58 %	6.08 %	0.39 %
Seq. Revenue Change	-3.79 %	10.05 %	-6.25 %	16.19 %	-9.1 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 25
Healthcare Sector	# 60
Overall Market	# 593

Receivable Turnover Ratio Statistics
High	Average	Low
1.28	1.09	0.77
(Mar 31 2026)		(Mar 31 2013)

ELMD Company Profile • Back to ELMD Efficiency Comparisons • Compare ELMD Receivables Turnover Ratio to its Competitors

Financial Statements
Electromed Inc 's Accounts Receivable	$ 30 Millions	Visit ELMD's Balance sheet
Electromed Inc 's Sales TTM	$ 75 Millions	Visit ELMD's Income Statement
Sources of ELMD's Revenues		Visit ELMD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ELMD's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ELMD's Growth Rates	ELMD's Roa	ELMD's Inventory Turnover Ratio	ELMD's Dividend Comparisons
ELMD's Profitability Ratios	ELMD's Roi	ELMD's Asset Turnover Ratio	ELMD's Dividend Growth
ELMD's Valuation Ratios	ELMD's Roe	ELMD's Financial Strength Ratios	ELMD's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Ceribell Inc	6.77	$ 109.203 Millions	$ 16.138 Millions
Medpace Holdings Inc	6.73	$ 2,838.385 Millions	$ 421.525 Millions
Beone Medicines Ltd	6.69	$ 6,606.279 Millions	$ 987.953 Millions
Carlisle Companies Incorporated	6.67	$ 5,213.500 Millions	$ 781.625 Millions
Iradimed Corporation	6.62	$ 89.340 Millions	$ 13.487 Millions
3m Company	6.59	$ 25,247.000 Millions	$ 3,832.500 Millions
Baxter International Inc	6.55	$ 11,784.000 Millions	$ 1,799.500 Millions
Haemonetics Corporation	6.48	$ 1,382.737 Millions	$ 213.396 Millions
Zevra Therapeutics Inc	6.40	$ 140.548 Millions	$ 21.947 Millions
Bruker Corporation	6.39	$ 3,512.500 Millions	$ 549.350 Millions
Labcorp Holdings Inc	6.38	$ 14,594.500 Millions	$ 2,286.925 Millions
Bionano Genomics Inc	6.36	$ 31.085 Millions	$ 4.888 Millions
Healthcare Services Group Inc	6.36	$ 1,879.860 Millions	$ 295.784 Millions
Intellia Therapeutics Inc	6.33	$ 52.887 Millions	$ 8.355 Millions
Gilead Sciences Inc	6.29	$ 30,988.000 Millions	$ 4,929.000 Millions
Integra Lifesciences Holdings Corp	6.26	$ 1,656.786 Millions	$ 264.861 Millions
Atara Biotherapeutics Inc	6.23	$ 4.019 Millions	$ 0.645 Millions
Orthofix Medical Inc	6.18	$ 835.683 Millions	$ 135.265 Millions
Neogen Corporation	6.17	$ 884.120 Millions	$ 143.371 Millions
Vertex Pharmaceuticals Inc	6.10	$ 12,951.600 Millions	$ 2,123.550 Millions
Mimedx Group Inc	6.06	$ 303.363 Millions	$ 50.077 Millions
Harvard Bioscience Inc	6.02	$ 90.339 Millions	$ 15.007 Millions
Rxsight Inc	6.00	$ 122.088 Millions	$ 20.336 Millions
Zai Lab Limited	5.99	$ 441.727 Millions	$ 73.769 Millions
Avantor Inc	5.98	$ 6,635.600 Millions	$ 1,110.300 Millions
Msa Safety Inc	5.96	$ 2,015.730 Millions	$ 338.388 Millions
Bio rad Laboratories Inc	5.92	$ 2,593.000 Millions	$ 437.800 Millions
Illumina Inc	5.87	$ 4,538.000 Millions	$ 773.500 Millions
Resmed Inc	5.82	$ 5,743.164 Millions	$ 986.765 Millions
Maxcyte inc	5.80	$ 34.374 Millions	$ 5.931 Millions

Date modified: 2026-11-11T13:41:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.